Increasing evidence has focusesed on the endocannabinoid system as a relevant player in the induction of aberrant synaptic plasticity and related addictive phenotype following chronic excessive alcohol drinking. In addition, the endocannabinoid system is implicated in the pathogenesis of alcoholic liver disease. Interestingly, whereas the involvement of CB1 receptors in alcohol rewarding properties is established, the central and peripheral action of CB2 signalling is still to be elucidated. This review aims at giving the input to deepen knowledge on the role of the endocannabinoid system, highlighting the advancing evidence that suggests that CB1 and CB2 receptors may play opposite roles in the regulation of both the reinforcing properties of alcohol in the brain and the mechanisms responsible for cell injury and inflammation in the hepatic tissue. The manipulation of the endocannabinoid system could represent a bi-faceted strategy to counteract alcohol-related dysfunction in central transmission and liver structural and functional disarrangement.

Lavanco G., Castelli V., Brancato A., Tringali G., Plescia F., Cannizzaro C. (2018). The endocannabinoid-alcohol crosstalk: Recent advances on a bi-faceted target. CLINICAL AND EXPERIMENTAL PHARMACOLOGY & PHYSIOLOGY., 45(9), 889-896 [10.1111/1440-1681.12967].

The endocannabinoid-alcohol crosstalk: Recent advances on a bi-faceted target

Lavanco G.;Castelli V.;Brancato A.;Plescia F.;Cannizzaro C.
2018-01-01

Abstract

Increasing evidence has focusesed on the endocannabinoid system as a relevant player in the induction of aberrant synaptic plasticity and related addictive phenotype following chronic excessive alcohol drinking. In addition, the endocannabinoid system is implicated in the pathogenesis of alcoholic liver disease. Interestingly, whereas the involvement of CB1 receptors in alcohol rewarding properties is established, the central and peripheral action of CB2 signalling is still to be elucidated. This review aims at giving the input to deepen knowledge on the role of the endocannabinoid system, highlighting the advancing evidence that suggests that CB1 and CB2 receptors may play opposite roles in the regulation of both the reinforcing properties of alcohol in the brain and the mechanisms responsible for cell injury and inflammation in the hepatic tissue. The manipulation of the endocannabinoid system could represent a bi-faceted strategy to counteract alcohol-related dysfunction in central transmission and liver structural and functional disarrangement.
2018
Settore BIO/14 - Farmacologia
Lavanco G., Castelli V., Brancato A., Tringali G., Plescia F., Cannizzaro C. (2018). The endocannabinoid-alcohol crosstalk: Recent advances on a bi-faceted target. CLINICAL AND EXPERIMENTAL PHARMACOLOGY & PHYSIOLOGY., 45(9), 889-896 [10.1111/1440-1681.12967].
File in questo prodotto:
File Dimensione Formato  
Lavanco_et_al-2018-Clinical_and_Experimental_Pharmacology_and_Physiology.pdf

Solo gestori archvio

Descrizione: articolo
Tipologia: Versione Editoriale
Dimensione 528.98 kB
Formato Adobe PDF
528.98 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
Lavancoetal.2018.pdf

accesso aperto

Tipologia: Post-print
Dimensione 627.88 kB
Formato Adobe PDF
627.88 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10447/366289
Citazioni
  • ???jsp.display-item.citation.pmc??? 8
  • Scopus 13
  • ???jsp.display-item.citation.isi??? 12
social impact